Marlen Haderlein

Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands

Florian Haller, Matthias Bieg, Rainer Will et al. · Nature Communications · 2019 · 211 citations · Full text

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 174 citations · Full text

Concurrent Chemoradiotherapy, Neoadjuvant Therapy, Squamous Cell Carcinoma +6

PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis

Markus Hecht, Maike Büttner‐Herold, Katharina Erlenbach‐Wünsch et al. · European Journal of Cancer · 2016 · 125 citations

Medicine, Cancer Growth, Pathology +8

Benchmarking ChatGPT-4 on a radiation oncology in-training exam and Red Journal Gray Zone cases: potentials and challenges for ai-assisted medical education and decision making in radiation oncology

Yixing Huang, Ahmed M. Gomaa, Sabine Semrau et al. · Frontiers in Oncology · 2023 · 107 citations · Full text

CD8+ and Regulatory T cells Differentiate Tumor Immune Phenotypes and Predict Survival in Locally Advanced Head and Neck Cancer

Alessia Echarti, Markus Hecht, Maike Büttner‐Herold et al. · Cancers · 2019 · 93 citations · Full text